| Management of glioblastoma: State of the art and future directions AC Tan, DM Ashley, GY López, M Malinzak, HS Friedman, M Khasraw CA: a cancer journal for clinicians 70 (4), 299-312, 2020 | 1358 | 2020 |
| Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96 … A Gajjar, M Chintagumpala, D Ashley, S Kellie, LE Kun, TE Merchant, ... The lancet oncology 7 (10), 813-820, 2006 | 1034 | 2006 |
| Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations MC Thompson, C Fuller, TL Hogg, J Dalton, D Finkelstein, CC Lau, ... Journal of clinical oncology 24 (12), 1924-1931, 2006 | 826 | 2006 |
| Recurrent glioblastoma treated with recombinant poliovirus A Desjardins, M Gromeier, JE Herndon, N Beaubier, DP Bolognesi, ... New England Journal of Medicine 379 (2), 150-161, 2018 | 732 | 2018 |
| Bone marrow–generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors DM Ashley, B Faiola, S Nair, LP Hale, DD Bigner, E Gilboa The Journal of experimental medicine 186 (7), 1177-1182, 1997 | 667 | 1997 |
| DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. HS Friedman, RE McLendon, T Kerby, M Dugan, SH Bigner, AJ Henry, ... Journal of Clinical Oncology 16 (12), 3851-3857, 1998 | 533 | 1998 |
| Brain immunology and immunotherapy in brain tumours JH Sampson, MD Gunn, PE Fecci, DM Ashley Nature Reviews Cancer 20 (1), 12-25, 2020 | 485 | 2020 |
| Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma RK Mulhern, SL Palmer, TE Merchant, D Wallace, M Kocak, P Brouwers, ... Journal of Clinical Oncology 23 (24), 5511-5519, 2005 | 468 | 2005 |
| Irinotecan therapy in adults with recurrent or progressive malignant glioma HS Friedman, WP Petros, AH Friedman, LJ Schaaf, T Kerby, J Lawyer, ... Journal of Clinical Oncology 17 (5), 1516-1516, 1999 | 418 | 1999 |
| Longitudinal molecular trajectories of diffuse glioma in adults FP Barthel, KC Johnson, FS Varn, AD Moskalik, G Tanner, E Kocakavuk, ... Nature 576 (7785), 112-120, 2019 | 404 | 2019 |
| Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma A Gajjar, R Hernan, M Kocak, C Fuller, Y Lee, PJ McKinnon, D Wallace, ... Journal of Clinical Oncology 22 (6), 984-993, 2004 | 354 | 2004 |
| Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors JH Sampson, LE Crotty, S Lee, GE Archer, DM Ashley, CJ Wikstrand, ... Proceedings of the National Academy of Sciences 97 (13), 7503-7508, 2000 | 255 | 2000 |
| Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma. HS Friedman, DM Kokkinakis, J Pluda, AH Friedman, I Cokgor, ... Journal of Clinical Oncology 16 (11), 3570-3575, 1998 | 254 | 1998 |
| Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the" immunologically privileged … JH Sampson, GE Archer, DM Ashley, HE Fuchs, LP Hale, G Dranoff, ... Proceedings of the National Academy of Sciences 93 (19), 10399-10404, 1996 | 247 | 1996 |
| Glioma progression is shaped by genetic evolution and microenvironment interactions FS Varn, KC Johnson, J Martinek, JT Huse, MLP Nasrallah, P Wesseling, ... Cell 185 (12), 2184-2199. e16, 2022 | 202 | 2022 |
| Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and … TE Merchant, LE Kun, MJ Krasin, D Wallace, MM Chintagumpala, SY Woo, ... International Journal of Radiation Oncology* Biology* Physics 70 (3), 782-787, 2008 | 198 | 2008 |
| Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer DA Caruso, LM Orme, AM Neale, FJ Radcliff, GM Amor, W Maixner, ... Neuro-oncology 6 (3), 236-246, 2004 | 193 | 2004 |
| Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive … D Strother, D Ashley, SJ Kellie, A Patel, D Jones-Wallace, S Thompson, ... Journal of Clinical Oncology 19 (10), 2696-2704, 2001 | 184 | 2001 |
| Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma HS Friedman, J Pluda, JA Quinn, RB Ewesuedo, L Long, AH Friedman, ... Journal of clinical oncology 18 (20), 3522-3528, 2000 | 170 | 2000 |
| White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor M Fouladi, M Chintagumpala, FH Laningham, D Ashley, SJ Kellie, ... Journal of Clinical Oncology 22 (22), 4551-4560, 2004 | 155 | 2004 |
